Inventor · disambiguated record
Defu Zeng
Also filed as: ZENG DEFU
4 granted patents·12 pending applications·18 citations·filing 2001–2024
69Inventor score
Top patents by PatentIndex Score
16 records- 0186US8277811B2Compositions and methods for inducing chimerism in a subjectZENG DEFU·Filed 2007·Granted Oct 2, 2012·15 cites·2 claims
- 0281US11116777B2Conditioning regimens and methods for inducing mixed chimerismHOPE CITY·Filed 2016·Granted Sep 14, 2021·2 cites·26 claims
- 0373US8110193B2Methods for conditioning a subject for hematopoietic cell transplantationZENG DEFU·Filed 2008·Granted Feb 7, 2012·1 cites·3 claims
- 0471US2025197498A1Methods for in vivo expansion of cd8+ t cells and prevention or treatment of gvhdHOPE CITY·Filed 2024·Application pending·0 cites
- 0566US11980629B2Conditioning regimens and methods for inducing mixed chimerismHOPE CITY·Filed 2021·Granted May 14, 2024·0 cites·10 claims
- 0662US2024325451A1Methods of inducing organ transplantation immune tolerance and associated compositions and methodsHOPE CITY·Filed 2024·Application pending·0 cites
- 0759US2020095321A1Methods for in vivo expansion of cd8+ t cells and prevention or treatment of gvhdHOPE CITY·Filed 2019·Application pending·0 cites
- 0858US2023277597A1Haploidentical mixed chimerism for treating autoimmune diseasesHOPE CITY·Filed 2023·Application pending·0 cites
- 0956US2024025990A1Prevention and treatment of graft-versus-host disease (gvhd)HOPE CITY·Filed 2021·Application pending·0 cites
- 1055US2024083998A1Prevention and treatment of steroid-resistant or gut graft-versus-host disease (gvhd)CIY OF HOPE·Filed 2022·Application pending·0 cites
- 1152US2006127399A1Compositions and methods for inducing chimerism in a subjectZENG DEFU·Filed 2005·Application pending·0 cites
- 1248US2020281976A1Prevention and treatment of gvhd and autoimmune diseasesHOPE CITY·Filed 2018·Application pending·0 cites
- 1345US2010055107A1Methods for preventing hematological malignancies and graft versus host disease by anti-cd3 preconditioningZENG DEFU·Filed 2009·Application pending·0 cites
- 1442US2001051156A1Methods for inhibition of polyclonal B cell activation and immunoglobulin class switching to pathogenic autoantibodies by blocking CD1-mediated interactionsFiled 2001·Application pending·0 cites
- 1539US2011038860A1Methods for inhibition of polyclonal b cell activation and immunoglobulin class switching to pathogenic autoantibodies by blocking cd1-mediated interactionsZENG DEFU·Filed 2010·Application pending·0 cites
- 1639US2019000889A1Methods for treating diabetesHOPE CITY·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Defu Zeng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →